In October, Singapore will celebrate the opening of the second major R&D hub that this Southeast Asian country has built this decade. The new, futuristic hub called Fusionopolis will feature research in the physical sciences and engineering to tackle global science and technology challenges. The 75-acre complex will be adjacent to Biopolis, which opened five years ago and is today cited by many other nations as a model -- and international competitor -- in the biomedical sciences. The force behind Singapore's development into a science center is A*STAR (Agency for Science, Technology and Research), which drives public sector research in biomedical sciences, and physical science and engineering in Singapore. Fusionopolis is not just about the convergence of sciences, but also the convergence of science with industry and society.